August 2008

Pfizer Defends Claims Against Parkinson’s Disease Drug in Bellwether MDL

United States - Minnesota

In its first bellwether MDL trial, Pfizer defended claims made by plaintiffs that they failed to warn of the side effects of their drug for Parkinson’s disease. Faegre Baker Daniels served as MDL liaison, co-trial and local counsel in Minnesota for the trial. Charbonneau v. Pfizer, Inc. et. al, No. 06-CV-1215, U.S. District Court, District of Minnesota.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。